The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Evidence for a wide extra-astrocytic distribution of S100B in human brain
Open accessAbstract
BACKGROUND: S100B is considered an astrocytic in-situ marker and protein levels in cerebrospinal fluid (CSF) or serum are often used as biomarker for astrocytic damage or dysfunction. However, studies on S100B in the human brain are rare. Thus, the distribution of S100B was studied by immunohistochemistry in adult human brains to evaluate its cell-type specificity. RESULTS: Contrary to glial fibrillary acidic protein (GFAP), which selectively labels astrocytes and shows only faint ependymal immunopositivity, a less uniform staining pattern was seen in the case of S100B. Cells with astrocytic morphology were primarily stained by S100B in the human cortex, while only 20% (14-30%) or 14% (7-35%) of all immunopositive cells showed oligodendrocytic morphology in the dorsolateral prefrontal and temporal cortices, respectively. In the white matter, however, most immunostained cells resembled oligodendrocytes [frontal: 75% (57-85%); temporal: 73% (59-87%); parietal: 79% (62-89%); corpus callosum: 93% (86-97%)]. S100B was also found in ependymal cells, the choroid plexus epithelium, vascular endothelial cells, lymphocytes, and several neurones. Anti-myelin basic protein (MBP) immunolabelling showed an association of S100B with myelinated fibres, whereas GFAP double staining revealed a distinct subpopulation of cells with astrocytic morphology, which solely expressed S100B but not GFAP. Some of these cells showed co-localization of S100B and A2B5 and may be characterized as O2A glial progenitor cells. However, S100B was not detected in microglial cells, as revealed by double-immunolabelling with HLA-DR. CONCLUSION: S100B is localized in many neural cell-types and is less astrocyte-specific than GFAP. These are important results in order to avoid misinterpretation in the identification of normal and pathological cell types in situ and in clinical studies since S100B is continuously used as an astrocytic marker in animal models and various human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · cited 1×
“This may have arisen from several postmortem studies on Alzheimer's disease and Down's syndrome describing predominant S100B immunostaining in reactive astrocytes surrounding neuritic plaques [14-16].”
BackgroundA soluble protein characteristic of the nervous system
Moore, B. W. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90320-7 · Cited by 1,695
Donato, R. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00046-2 · Cited by 1,580
Physiological and Biochemical Aspects of Nervous Integration
Carlson, F. D. (1968) · Cited by 749
Hsu, S. M., & Soban, E. (1982) · Journal of Histochemistry & Cytochemistry · doi:10.1177/30.10.6182185 · Cited by 659
Histology and Histopathology of the Nervous System
Moossy, J. (1982) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198209000-00010 · Cited by 424
S100β Induces Neuronal Cell Death Through Nitric Oxide Release from Astrocytes
Hu, J., Ferreira, A., & Van Eldik, L. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062294.x · Cited by 336
Wunderlich, M. T., Ebert, A. D., Kratz, T., Goertler, M., Jost, S., & Herrmann, M. (1999) · Stroke · doi:10.1161/01.str.30.6.1190 · Cited by 251
Mrak, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00293-7 · Cited by 248
Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization
Steiner, J., Mawrin, C., Ziegeler, A., Bielau, H., Ullrich, O., Bernstein, H.-G., & Bogerts, B. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0090-8 · Cited by 229
Self-citationEffects of Head and Extracranial Injuries on Serum Protein S100B Levels in Trauma Patients
Savola, O., Pyhtinen, J., Leino, T. K., Siitonen, S., Niemel??, O., & Hillbom, M. (2004) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000096644.08735.72 · Cited by 222
Jessen, K. R., Thorpe, R., & Mirsky, R. (1984) · Journal of Neurocytology · doi:10.1007/bf01148114 · Cited by 220
Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease
Peskind, E. R., Griffin, W. S. T., Akama, K. T., Raskind, M. A., & Van Eldik, L. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00048-1 · Cited by 215
S100b expression in and effects on microglia
Adami, C., Sorci, G., Blasi, E., Agneletti, A. L., Bistoni, F., & Donato, R. (2001) · Glia · doi:10.1002/1098-1136(200102)33:2<131::aid-glia1012>3.0.co;2-d · Cited by 210
Histology and histopathology of the nervous system
Haymaker, W., & Adams, R. D. (1982) · Thomas eBooks · Cited by 195
Sheng, J. G., Mrak, R. E., & Griffin, W. S. T. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390406 · Cited by 185
Spatial and temporal expression of S100B in cells of oligodendrocyte lineage
Hachem, S., Aguirre, A., Vives, V., Marks, A., Gallo, V., & Legraverend, C. (2005) · Glia · doi:10.1002/glia.20184 · Cited by 161
Vives, V., Alonso, G., Solal, A. C., Joubert, D., & Legraverend, C. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10552 · Cited by 161
Deloulme, J. C., Raponi, E., Gentil, B. J., Bertacchi, N., Marks, A., Labourdette, G., & Baudier, J. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.07.008 · Cited by 159
Immunocytochemical localization of S-100 protein in the brain of adult rat
Cocchia, D. (1981) · Cell and Tissue Research · doi:10.1007/bf00233493 · Cited by 151
Raised Serum S100B Levels after Acute Bone Fractures without Cerebral Injury
n, J. U., Bellner, J., Eneroth, M., Alling, C., Ingebrigtsen, T., & Romner, B. (2005) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000130613.35877.75 · Cited by 149
S100 protein expression in subpopulations of neurons of rat brain
Rickmann, M., & Wolff, J. R. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00615-c · Cited by 144
Active secretion of S100B from astrocytes during metabolic stress
Gerlach, R., Demel, G., König, H., Groß, U., Prehn, J. H. M., Raabe, A., Seifert, V., & Kögel, D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.008 · Cited by 137
S100B is increased in mood disorders and may be reduced by antidepressive treatment
Schroeter, M. L., Abdul‐Khaliq, H., Diefenbacher, A., & Blasig, I. E. (2002) · Neuroreport · doi:10.1097/00001756-200209160-00021 · Cited by 130
Steiner, J. H., Bielau, H., Hg, B., Bogerts, B., & Wunderlich, M. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.093427 · Cited by 122
Self-citationINCREASED LEVELS OF SERUM S100B PROTEIN IN CRITICALLY ILL PATIENTS WITHOUT BRAIN INJURY
Routsi, C., Stamataki, E., Nanas, S., Psachoulia, C., Σταθόπουλος, Α., Koroneos, A., Zervou, M., Jullien, G., & Roussos, C. (2006) · Shock · doi:10.1097/01.shk.0000209546.06801.d7 · Cited by 120
Bianchi, R., Giambanco, I., & Donato, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31440-6 · Cited by 113
Increase in Serum S100B Protein Level After a Swimming Race
Dietrich, M. O., Tort, A. B. L., Schaf, D. V., Farina, M., Gonçalves, C. A., Souza, D. O., & Portela, L. V. (2003) · Canadian Journal of Applied Physiology · doi:10.1139/h03-054 · Cited by 99
Glial Progenitors in the CNS and Possible Lineage Relationships Among Them
Liu, Y., & Rao, M. S. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.02.001 · Cited by 91
Friend, W. C., Clapoff, S., Landry, C. F., Becker, L. E., O'Hanlon, D., Allore, R., Brown, I. R., Marks, A., Roder, J., & Dunn, R. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04337.1992 · Cited by 87
Relationship between stress and circulating levels of S100B protein
Scaccianoce, S., Bianco, P. D., Pannitteri, G., & Passarelli, F. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.028 · Cited by 84
Histochemistry and immunocytochemistry of the developing ependyma and choroid plexus
Sarnat, H. B. (1998) · Microscopy Research and Technique · Cited by 84
Differential expression of S100B and S100A61 in the human fetal and aged cerebral cortex
Tiu, S. C., Chan, W. Y., Heizmann, C. W., Schäfer, B. W., Shu, S., & Yew, D. T. W. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00151-0 · Cited by 83
Calcium-regulated Interaction of Sgt1 with S100A6 (Calcyclin) and Other S100 Proteins
Nowotny, M., Spiechowicz, M., Jastrzębska, B., Filipek, A., Kitagawa, K., & Kuźnicki, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211518200 · Cited by 78
S-100β has a neuronal localisation in the rat hindbrain revealed by an antigen retrieval method
Yang, Q., Hamberger, A., Hydén, H., Wang, S., Stigbrand, T. I., & Haglid, K. G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00755-f · Cited by 78
Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast
Viale, G., Gambacorta, M., Coggi, G., Dell’Orto, P., Milani, M., & Doglioni, C. (1991) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01600164 · Cited by 76
Dyck, R. H., Eldik, L. J. V., & Cynader, M. S. (1993) · Developmental Brain Research · doi:10.1016/0165-3806(93)90183-b · Cited by 73
Koppal, T., Lam, A. G. M., Guo, L., & Eldik, L. J. V. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00047-x · Cited by 71
Serum S100B Protein Is Increased in Fasting Rats
Netto, C. B. O., Conte, S., Leite, M. C., Pires, C., Martins, T. L., Vidal, P. R., Benfato, M. S., Giugliani, R., & Gonçalves, C. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.11.005 · Cited by 63
High Glutamate Decreases S100B Secretion by a Mechanism Dependent on the Glutamate Transporter
Tramontina, F. F., Leite, M. C., Gonçalves, D. D. S., Tramontina, A. C., Souza, D. F., Frizzo, J. K., Nardin, P., Gottfried, C., Wofchuk, S. T., & Gonçalves, C. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9085-z · Cited by 59
Neuronal modulation of schwann cell glial fibrillary acidic protein (GFAP)
Mokuno, K., Kamholz, J. A., Behrman, T., Black, C., Sessa, M., Feinstein, D. L., Lee, V., & Pleasure, D. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490230405 · Cited by 58
Li, D., Zhu, B.-L., Ishikawa, T., Zhao, D., Michiue, T., & Maeda, H. (2005) · Legal Medicine · doi:10.1016/j.legalmed.2005.09.002 · Cited by 48
S100 immunoreactivity in a subpopulation of oligodendrocytes and Ranvier's nodes of adult rat brain
Rickmann, M., & Wolff, J. R. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11269-3 · Cited by 45
Riol, H., Tardy, M., Rolland, B., L�vesque, G., & Murthy, M. R. V. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970401)48:1<53::aid-jnr5>3.0.co;2-d · Cited by 38
Lins, H., Wallesch, C. W., & Wunderlich, M. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00484.x · Cited by 29
Alemán, M., Monzón-Mayor, M., Yanes, C. M., Arbelo-Galván, J.-F., Lang, D. M., Renau‐Piqueras, J., & Negrín‐Martínez, C. (2003) · Journal of Neurobiology · doi:10.1002/neu.10258 · Cited by 28
Changes in S100B cerebrospinal fluid levels of rats subjected to predator stress
Margis, R., Zanatto, V. C., Tramontina, F. F., Vinadé, E. R., Lhullier, F. L. R., Portela, L. V., Souza, D. O., Dalmaz, C., Kapczinski, F. P., & Gonçalves, C. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.013 · Cited by 28
Macrophages express glial markers
Alliot, F., & Pessac, B. (1988) · Biology of the Cell · doi:10.1016/0248-4900(88)90115-3 · Cited by 12
Cited by
Verkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678
“In the CNS it is expressed not only in astroglia but also in oligodendrocytes, in ependymal cells, in the choroid plexus epithelium, in vascular endothelial cells, in lymphocytes, and in some neurons (1664), in particular in neurons in the brain stem, cerebellum, forebrain, and the limbic system (1466).”
Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
Astrocyte Heterogeneity: Impact to Brain Aging and Disease
Matias, I., Morgado, J., & Gomes, F. C. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00059 · Cited by 387
Ependymal cells: biology and pathology
Del Bigio, M. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0624-y · Cited by 386
Astrocyte phenotype in relation to Alzheimer‐type pathology in the ageing brain
Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.015 · Cited by 381
Metadata
- Authors
- Steiner, J., Bernstein, H.-G., Bielau, H., Berndt, A., Brisch, R., Mawrin, C., Keilhoff, G., & Bogerts, B.
- Venue
- BMC Neuroscience
- Published
- 2007-01-02
- Volume
- 8
- Issue
- 1
- Pages
- 2-2
- ISSN
- 1471-2202 (ISSN-L)
- OpenAlex
- W2103360825
- Cited by
- 283
- References
- 48
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.